Summary
Overview
Work History
Education
Skills
Timeline
Generic

Dong-Joon Oh

Suwon,45

Summary

Accomplished pharmaceutical R&D leader with over 15 years of experience in formulation development, modified-release technologies, and fixed-dose combination (FDC) products. Proven track record in leading multi-disciplinary teams, securing government-funded research grants, and executing successful technology transfers with global and domestic pharmaceutical partners. Recognized for expertise in BE/PK study design, IND/CTD dossier preparation, and regulatory strategy. A visionary leader driving innovation through strategic planning, drug repositioning, and cross-functional collaboration.

Overview

19
19
years of professional experience

Work History

Research

Han Wha Pharma Co., Ltd
01.2022 - Current
  • Planned and executed 15 R&D projects with successful research proposals
  • Led technology transfer and licensing deals for 8 products across 20 pharmaceutical partners
  • Acquired government funding for national projects
  • Spearheaded Drug Repositioning initiatives

Research

Hyundai Pharm Co., Ltd. / Bio-innotis
06.2018 - 12.2021
  • Oversaw all activities from planning to formulation, analysis, and regulatory submission
  • Successfully submitted 12 IND/CTD dossiers (domestic & overseas) for clinical trials
  • Selected as "Excellent Researcher of 2019"
  • Appointed "Best Clinical Submission Awardee" in 2020

Reseach

Celltrion Pharm, Inc.
06.2014 - 06.2018
  • GGP TL (Technical Leader) for Celltrion's first FDA-approved generic
  • Led new formulation and platform development (8 BDPs and 5 pipeline technologies)
  • Developed and launched 33 new formulations
  • Achieved excellence in platform R&D and scale-up strategies

Research

Yungjin Pharmaceutical Co., Ltd.
10.2006 - 05.2014
  • Developed and registered 7 generics for domestic sales
  • Led 13 API source registration projects including 4 complex raw material formulations
  • Conducted development of new drugs 1, 4, 5 (non-clinical/clinical/formulation)
  • Appointed as PL (Project Leader) in 2013

Education

Ph.D. - Pharmacy

Yonsei University
Incheon, South Korea
01-2026

Master of Science - Chemical Engineering

Hannam University
Daejeon, South Korea
02-2007

Bachelor of Science - Nano Life Science And Chemical Engineering

Hannam University
Daejeon, South Korea
02-2005

Skills

  • Pharmaceutical formulation development
  • IND/CTD dossier preparation (domestic and international)
  • Drug repositioning strategies
  • Government project proposal and management
  • Analytical method development and validation
  • Bioequivalence and pharmacokinetics (BE/PK) studies
  • Technology transfer & licensing coordination
  • Clinical trial planning and CRO collaboration
  • Regulatory affairs and product registration
  • R&D team leadership and project management

Timeline

Research

Han Wha Pharma Co., Ltd
01.2022 - Current

Research

Hyundai Pharm Co., Ltd. / Bio-innotis
06.2018 - 12.2021

Reseach

Celltrion Pharm, Inc.
06.2014 - 06.2018

Research

Yungjin Pharmaceutical Co., Ltd.
10.2006 - 05.2014

Ph.D. - Pharmacy

Yonsei University

Master of Science - Chemical Engineering

Hannam University

Bachelor of Science - Nano Life Science And Chemical Engineering

Hannam University
Dong-Joon Oh